Introduction
Adipose tissue plays an important role in storage of excessive nutrients and regulating energy balance. Due to limited ability of adipocytes for fat depositing, overnutrition generates the production of oxygen free radicals resulting in oxidative stress and consequently inflammation. In obesity, low-grade inflammatory status is primarily caused by the activity of adipocytes and immune cells secreting various pro-inflammatory molecules, such as e.g. receptor 1 and receptor 2 for tumor necrosis factor-alpha, pentraxin 3, interleukin 15, monocyte chemoattractant protein-1, soluble intercellular adhesion molecule-1 or soluble CD40 Ligand. All these signaling molecules are responsible for i.a. chronic systemic inflammation, adipogenesis, atherosclerosis, insulin resistance, and their severe consequences like cardiovascular diseases, diabetes, metabolic disorders, carcinogenesis, severe asthma [1] [2] [3] [4] [5] .
New molecular technologies within the last decade focused on analyses salivary proteome and transcriptome. Saliva has been studied as an alternative biological fluid in the non-invasive diagnostics of several systemic diseases, such as endocrine, cardiovascular, autoimmune or infectious diseases [6, 7] .
Saliva is generally composed of water (ca. 99%), different proteins (e.g. enzymes, immunoglobulins) and electrolytes (e.g. sodium, calcium). All these substances are provided to saliva mainly by salivary glands, gingival crevices and upper respiratory mucosa. Majority of blood components passes to saliva using intracellular mechanisms, such as passive or active transport or ultrafiltration between cell junctions, by analogy to renal production of urine. In patients with obesity, concentrations of several markers identified in blood and saliva (like inflammatory cytokines, adipokines or cortisol) are correlated between blood and saliva [8, 9] . Saliva collection is less stressful for the patients, also easy and requires no qualified personnel. These findings indicate that salivary biomarkers have valuable potential for developing new non-invasive diagnostic techniques.
The study aims to evaluate selected inflammatory markers in the saliva of people with obesity and determine their discriminatory values (as an alternative biological fluid to blood).
Patients and methods

Patients
One-hundred-and-twenty-five (82 female and 43 male) subjects aged between 20 to 65 years were included in the study. The study group included 59 patients (body mass index >30 kg/m 2 ) from the Department of Internal and Metabolic Diseases, Poznan University of Medical Sciences (PUMS), and the control group comprised 66 patients (BMI <25 kg/m 2 ) from the Department of Conservative Dentistry and Periodontology, Poznan University of Medical Sciences. The following criteria were used to exclude subjects: diabetes, change in body weight ± 3 kg within the last three months, history of surgical treatment for obesity, pregnancy or use of contraceptive agents. This study was approved by the Bioethical Commission at PUMS (No. 189/14). Every patient was informed about the aim and type of research to be carried out and signed written consents for participation were obtained from all patients. All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Saliva collection
Unstimulated mixed saliva was used for laboratory studies. Saliva was collected at a specific time of the day, i.e., between 10 a.m. and 1 p.m. All samples were collected at least 2 hours after a meal. For proper saliva flow into calibrated tubes on ice, patients were seated in an upright position with their trunks bent forward and were asked to hold swallowing. The tubes containing saliva were kept on ice at all times during the experiment. The unstimulated saliva was collected for a total of 20 minutes and the secreted amount was calculated in ml/min. Immediately after calculation, the saliva was centrifuged for 10 minutes with 2000 rpm using 
Statistical analysis
The Shapiro-Wilk test was used to verify normal distribution of the results and nonparametric methods were used for analyses of results that were not normally distributed.
The comparison between the study group and control group with respect to the previously mentioned parameters was conducted using the Mann-Whitney's test. The Spearman's rank test was used to measure the degree of association between measured variables. Also, ROC curves (receiver operating characteristic curves) were analyzed for tested salivary markers.
The significance level was estimated at α=0.05. The analyses were performed using the Statistica 13.1 software (StatSoft, Cracow, Poland).
Results
Patients' characteristics, including the detailed demographic and physical parameters of the subjects, are shown in Table 1 .
The amount of unstimulated saliva secreted by these patients with obesity was statistically lower when compared with the normal-weight individuals. However, salivary pH was not lower in the group with obesity.
There were statistically significant differences in the concentrations of all inflammatory markers in saliva, between patients with obesity and patients with normal weight (Figures 1a-1g ). Statistical significance was observed in correlations between different inflammatory markers of both groups. The correlation coefficients are presented in Table 2 .
Moreover, the analysis of ROC curves by gender was performed to assess the ability of salivary markers to discriminate obesity and determine potentially optimal cut-off points for them. The results are shown in Table 3 and Figure 2 . All markers had discriminatory value for obesity but the best was sCD40L. It is worth noting that unlike other markers, lower levels of this ligand are related to higher risk of obesity.
Discussion
The saliva of individuals with obesity showed statistically higher concentrations of all studied cytokines, except sCD40L. The present study proves that significant differences exist between components and properties of saliva originating from patients with obesity and individuals with normal body weights.
Previously published studies have shown that, in individuals with obesity, there is moderate persistent underlying inflammation in the parotid glands coupled with inflammatory mediators secreted by adipose tissue and acting along the hypothalamic-pituitary-adrenal axis, which could be contributing to the reduced activity of salivary glands [10] . Although the amount of saliva was lower, we did not observe any difference in pH between the saliva in both groups of our study.
Our results demonstrated that it is possible to estimate, not only in blood but also in saliva, the concentrations of cytokines produced in cells of adipose tissue.
A recognized marker of inflammation is MCP-1. Blood MCP-1 concentrations have been used in the diagnosis and to estimate the prognosis of several diseases, such as nephritis, rheumatoid arthritis, and cardiovascular diseases [11, 12] . Currently, an increased number of investigators are now analyzing the concentrations of cytokines in saliva, in addition to blood. [14] . Its concentration in children with obesity was 174.1 pg/ml, similar to the level seen in our study. Currently, ongoing investigations have continued to use salivary MCP-1 in the evaluation of tissue damage and in treatment prognosis of head and neck tumors [15] .
Another cytokine we studied was the CD40/CD40L complex. It participates in the inflammatory cascade in several autoimmune diseases, including systemic lupus and rheumatoid arthritis [16] . The results of several studies have shown that the CD40/CD40L complex, estimated either in blood or in serum, provides a useful biomarker for the diagnosis of Sjögren's syndrome [17] . It was also shown that, in Sjögren's, the CD40/CD40L complex plays a role in the process of programmed cell death or apoptosis. We found, that the best discriminatory value for obesity has sCD40L, regardless of patients' sex (the highest area under the curve values among tested markers). As sCD40L is a destimulant, based on a determined optimal cut-off point, its salivary concentrations below 3.28 pg/ml can be considered as a potential prognostic of obesity. In contrast, all other parameters belong to stimulants and their cut-off threshold is a measurement above which the probability of obesity potentially increases.
The concentration of sICAM-1 in saliva is statistically higher in individuals with obesity when compared with individuals without obesity (609.12 pg/ml vs 395.89 pg/ml). This difference may point to an increased risk for leukocyte (particularly monocytes) adhesion to the vascular endothelium, which, consequently, leads to the formation of foam cells in arteriosclerotic plaque [18] . According to previous studies, increased blood concentrations of sICAM-1 may be observed in asthma, allergic or autoimmune inflammation of the skin, and in tumors. Numerous other studies have reported high levels of sICAM-1 in the saliva of individuals diagnosed with periodontal disease [19] .
In our study, a statistically significant difference was detected in the salivary TNFα-R1 was only 45.0 pg/ml in the group of healthy individuals [21] .
We also assessed changes in PTX-3, a known serum biomarker used for the evaluation of complications of cardiovascular events and for the assessment of arteriosclerotic process advancement [22] . Recent studies have shown that, in addition to the known uses of PTX-3, its estimation in the saliva is helpful in early diagnosis and estimation of prognosis related to periodontal diseases [23] . Our study showed a higher concentration of PTX-3 in individuals with obesity (420.28 pg/ml) when compared with normal-weight individuals (272.33 pg/ml). IL-15, another important inflammatory cytokine, also showed a statistically significant difference between the two groups in our study. In the group with obesity, a median concentration of 11.71 pg/ml was measured while a concentration of 8.60 pg/ml was measured in the control group. The study by Phalane et al. showed that the level of IL-15 in the saliva of patients with tuberculosis was 0.6 pg/ml. IL-15 was undetected in the serum [24] .
In addition, the study by Khan discussed earlier in this paper, stated that the concentration of IL-15 could not be estimated in blood, urine, or saliva [13] .
Conclusion
The results presented here will shed more light on understanding the link between inflammation and obesity. This will allow for better monitoring of general health conditions in patients with obesity and will also aid in formulating more accurate prognoses. Our study has revealed several positive correlations between inflammatory markers and excessive body weight. Hopefully, this will aid the implementation of appropriate steps to screen individuals at risk for obesity and, thus, implement proper preventative guidelines.
The saliva of patients in the study group contained higher concentrations of all the measured inflammatory markers. Salivary biomarkers have the potential to aid in the diagnosis of other systemic diseases, including many of those which are a consequence of obesity.
Our study could help to understand the pathomechanism of obesity. Establishing typical values for the pro-inflammatory cytokines in saliva would allow better monitoring of general health in patients with obesity. Further research is necessary to implement systemic solutions for patients with obesity. 
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